16 Patents
- 0 cites
- 0 cites
- US122408402025Amide-substituted Heterocyclic Compounds for the Treatment of Conditions Related to the Modulation of IL-12, IL-23 And/or Ifn-alpha
Bristol-myers Squibb Company
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- USRE0499312024[1,2,4]triazolo[1,5-a]pyridinyl Substituted Indole Compounds
Bristol-myers Squibb Company
0 cites - USRE0498932024[1,2,4]triazolo[1,5-a]pyridinyl Substituted Indole Compounds
BRISTOL-MYERS SQUIBB COMPANY
0 cites - USRE0498802024[1,2,4]triazolo[1,5-a]pyridinyl Substituted Indole Compounds
BRISTOL-MYERS SQUIBB COMPANY
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US116727802023[1,2,4]triazolo[1,5-a]pyridinyl Substituted Indole Compounds
Bristol-myers Squibb Company
0 cites